Locate Annapolis buprenorphine and suboxone doctors who specialize in the treatment of opioid addiction.
Featured Provider New Journey |
|
Dr. Kari Fai Alperovitz-Bichell, M.D.
AAMC Community Clinic at Morris Blum
701 Glenwood Street
Annapolis, MD 21401
Main Tel: (410) 990-0050
|
|
Dr. Wilfredo Gamez, M.D.
90 Edgewood Ave
Annapolis, MD 21403
Main Tel: (443) 392-2049
|
|
Dr. Rajendra Lowtan, M.D.
1831 B Forest Drive
Suite 4
Annapolis, MD 21401
Main Tel: 410-290-8800
|
|
Dr. Yura K. Jarrells, M.D.
1831 Forest Drive
Suite D
Annapolis, MD 21401
Main Tel: (410) 268-8191
|
|
Dr. Laura Ebner, M.D.
914 Forest Drive
Suite 202
Annapolis, MD 21403
Main Tel: (410) 635-0465
|
|
Jon Bishop Lowe, M.D.
2009 Tidewater Colony Drive
Annapolis, MD 21401
Main Tel: (410) 224-0010
|
|
Dr. Chinenye S. Ekoh,
OASIS, Center for Mental Health
175 Admiral Cochrane Drive, Suite 100
Annapolis, MD 21401
Main Tel: (410) 571-0888
|
|
Dr. Titus Chotheakadavil Abraham, M.D.
Suite 400
116 Defense Highway
Annapolis, MD 21401
Main Tel: (410) 897-9841
|
|
Dr. Robert Alan Herman, M.D.
Spectrum Behavioral Health
1509 Ritchie Highway #2F
Arnold, MD 21012
Main Tel: (410) 757-2077
|
|
Dr. Raymond Stephen Hoffman, M.D.
2635 Riva Road
Suite 108
Annapolis, MD 21401
Main Tel: (410) 573-9000
|
|
Linda Whitby, M.D.
3666 Muddy Creek Road
OASIS FOUNDATION
Edgewater, MD 21037
Main Tel: (443) 203-0103
|
|
Harold Oliver Alexander, M.D.
3666 Muddy Creek Road
Edgewater, MD 21037
Main Tel: (301) 377-6703
|
|
Dr. Lee Adam Goodman, M.D.
79 West Street
Annapolis, MD 21401
Main Tel: (410) 268-3627
|
|
Dr. Pradeep Garg, M.D.
4304 Mountain Road
Pasadena, MD 21122
Main Tel: (410) 360-2400
|
The Drug Treatment Act of 2000 permitted doctors who meet certain training qualifications to prescribe buprenorphine in the treatment of heroin addiction and other opioid addictions. Buprenorphine physicians became able to assist opioid addicted patients in an office setting bypassing the restrictions that typically apply to patients receiving methadone. This treatment method maximized patient convenience and accessibility thus increasing the number of people who could access medication-assisted treatment (MAT) for opioid addiction.